menu

Investigating T2 Inflammation in Severe Asthma & COPD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Investigating T2 Inflammation in Severe Asthma & COPD

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
Completing the pre-test is required to view this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • In Partnership with

  • Overview

    Type 2 inflammation can be challenging to identify. What should we be looking for in our patients with severe asthma and COPD? Joining Dr. Peter Howarth to discuss identifying this type of inflammation are Dr. Geoffrey Chupp from the Yale School of Medicine and Dr. Ian Pavord from the University of Oxford.

    This is a nonpromotional, non-CME disease state educational podcast brought to you by the American College of CHEST Physicians in collaboration with and paid for by GSK.

  • References

    1.Stevens WW, et al. J Allergy Clin Immunol. 2015;136:1442–1453.
    2. Ho J, et al. Clin Exp Allergy. 2015;45:394–403.
    3. Naclerio R, et al. J Allergy Clin Immunol Pract. 2020;8:1532–1549.e1.
    4. Cao PP, et al. Ann Allergy Asthma Immunol. 2019;122:33–40.
    5. Ahern S & Cervin A. Medicina (Kaunas). 2019;55:95.
    6. Kim J & Naclerio R. Ther Clin Risk Manag. 2020;16:31–37.
    7. Takatsu K. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87:463–485.
    8. Greenfeder S, et al. Respir Res. 2001;2:71-79.
    9. Buchheit KM, et al. J Allergy Clin Immunol. 2021;148(2):574-584.
    10. Buchheit KM, et al. J Allergy Clin Immunol. 2020;145(6):1574-1584.
    11. Gitomer SA, et al. Otolaryngol Head Neck Surg. 2016;155(1):173-178.
    12. Simon H-U, et al. J Immunol. 1997;158(8):3902-3908.
    13. Kato A, et al. J Allergy Clin Immunol. 2022. Epub ahead of print.
    14. Bachert C, et al. J Allergy Clin Immunol. 1997;99(6 Pt 1):837–842.
    15. Sun C, et al. Braz J Otorhinolaryngol. 2017;83:66–72.
    16. Fokkens WJ, et al. Rhinology. 2020;58(Suppl S29):1–464.
    17. Calus L, et al. Clin Trans Allerg. 2019;9:30.
    18. Stevens WW, et al. Am J Respir Crit Care Med. 2015;192(6):682-694.
    19. Buchheit KM, Hulse KE. Ann Allergy Asthma Immunol. 2021;126(2):127-134.
    20. Gevaert P, et al. Int Forum Allergy Rhinol. 2022. Epub ahead of print.
    21. Vanderhaegen T, et al. Clin Rev Allergy Immunol. 2022;62(1):90-102.
    22. Chang SW, et al. Clin Otolaryngol. 2021;46(2):304-31.
    23. Gevaert P, et al. J Allergy Clin Immunol. 2020;146(3):595-605.
    24. Barretto KT, et al. Allergy. 2020;75(8):2127-2130.
    25. Lee K, et al. Int J Mol Sci. 2021;22:910.
    26. Dwyer DF, et al. Sci Immunol. 2021;6(56):eabb7221.
    27. Galdiero MR, et al. Front Med. 2017;4:103.
    28. Ochi H, et al. Proc Natl Acad Sci. 2000;97:10509–10513.
    29. Thivierge M, et al. J Immunol. 2001;167:2855–2860.
    30. Fujieda S, et al. Allergol Int. 2019;68:403–412.
    31. Newton JR & Ah-See KW. Ther Clin Risk Manag. 2008;4:507–512.

Facebook Comments

Recommended
Details
Presenters
Comments
  • In Partnership with

  • Overview

    Type 2 inflammation can be challenging to identify. What should we be looking for in our patients with severe asthma and COPD? Joining Dr. Peter Howarth to discuss identifying this type of inflammation are Dr. Geoffrey Chupp from the Yale School of Medicine and Dr. Ian Pavord from the University of Oxford.

    This is a nonpromotional, non-CME disease state educational podcast brought to you by the American College of CHEST Physicians in collaboration with and paid for by GSK.

  • References

    1.Stevens WW, et al. J Allergy Clin Immunol. 2015;136:1442–1453.
    2. Ho J, et al. Clin Exp Allergy. 2015;45:394–403.
    3. Naclerio R, et al. J Allergy Clin Immunol Pract. 2020;8:1532–1549.e1.
    4. Cao PP, et al. Ann Allergy Asthma Immunol. 2019;122:33–40.
    5. Ahern S & Cervin A. Medicina (Kaunas). 2019;55:95.
    6. Kim J & Naclerio R. Ther Clin Risk Manag. 2020;16:31–37.
    7. Takatsu K. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87:463–485.
    8. Greenfeder S, et al. Respir Res. 2001;2:71-79.
    9. Buchheit KM, et al. J Allergy Clin Immunol. 2021;148(2):574-584.
    10. Buchheit KM, et al. J Allergy Clin Immunol. 2020;145(6):1574-1584.
    11. Gitomer SA, et al. Otolaryngol Head Neck Surg. 2016;155(1):173-178.
    12. Simon H-U, et al. J Immunol. 1997;158(8):3902-3908.
    13. Kato A, et al. J Allergy Clin Immunol. 2022. Epub ahead of print.
    14. Bachert C, et al. J Allergy Clin Immunol. 1997;99(6 Pt 1):837–842.
    15. Sun C, et al. Braz J Otorhinolaryngol. 2017;83:66–72.
    16. Fokkens WJ, et al. Rhinology. 2020;58(Suppl S29):1–464.
    17. Calus L, et al. Clin Trans Allerg. 2019;9:30.
    18. Stevens WW, et al. Am J Respir Crit Care Med. 2015;192(6):682-694.
    19. Buchheit KM, Hulse KE. Ann Allergy Asthma Immunol. 2021;126(2):127-134.
    20. Gevaert P, et al. Int Forum Allergy Rhinol. 2022. Epub ahead of print.
    21. Vanderhaegen T, et al. Clin Rev Allergy Immunol. 2022;62(1):90-102.
    22. Chang SW, et al. Clin Otolaryngol. 2021;46(2):304-31.
    23. Gevaert P, et al. J Allergy Clin Immunol. 2020;146(3):595-605.
    24. Barretto KT, et al. Allergy. 2020;75(8):2127-2130.
    25. Lee K, et al. Int J Mol Sci. 2021;22:910.
    26. Dwyer DF, et al. Sci Immunol. 2021;6(56):eabb7221.
    27. Galdiero MR, et al. Front Med. 2017;4:103.
    28. Ochi H, et al. Proc Natl Acad Sci. 2000;97:10509–10513.
    29. Thivierge M, et al. J Immunol. 2001;167:2855–2860.
    30. Fujieda S, et al. Allergol Int. 2019;68:403–412.
    31. Newton JR & Ah-See KW. Ther Clin Risk Manag. 2008;4:507–512.

Facebook Comments

Schedule18 May 2022
Webpack App